Product Description
Synedica Reta 40mg is a prefilled or multi-dose injectable product containing retatrutide, an investigational triple-hormone receptor agonist (targeting GLP-1, GIP, and glucagon receptors) developed originally by Eli Lilly for weight management and type 2 diabetes research.